PDB Short entry for 1E03 HEADER BLOOD CLOTTING 09-MAR-00 1E03 TITLE PLASMA ALPHA ANTITHROMBIN-III AND PENTASACCHARIDE CAVEAT 1E03 NAG A 2 HAS WRONG CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANTITHROMBIN-III; COMPND 3 CHAIN: I, L SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 OTHER_DETAILS: PLASMA ALPHA ANTITHROMBIN-III KEYWDS BLOOD CLOTTING, SERPIN EXPDTA X-RAY DIFFRACTION AUTHOR A.J.MCCOY,L.JIN,J.-P.ABRAHAMS,R.SKINNER,R.W.CARRELL REVDAT 6 06-DEC-23 1E03 1 HETSYN REVDAT 5 29-JUL-20 1E03 1 CAVEAT COMPND REMARK HET REVDAT 5 2 1 HETNAM FORMUL LINK SITE REVDAT 5 3 1 ATOM REVDAT 4 24-FEB-09 1E03 1 VERSN REVDAT 3 14-JUN-01 1E03 1 REMARK FORMUL SSBOND LINK REVDAT 3 2 1 ATOM TER HETATM CONECT REVDAT 3 3 1 MASTER REVDAT 2 18-AUG-00 1E03 1 HET REVDAT 1 02-JUN-00 1E03 0 JRNL AUTH A.J.MCCOY,X.Y.PEI,R.SKINNER,J.-P.ABRAHAMS,R.W.CARRELL JRNL TITL STRUCTURE OF BETA-ANTITHROMBIN AND THE EFFECT OF JRNL TITL 2 GLYCOSYLATION ON ANTITHROMBIN'S HEPARIN AFFINITY AND JRNL TITL 3 ACTIVITY. JRNL REF J.MOL.BIOL. V. 326 823 2003 JRNL REFN ISSN 0022-2836 JRNL PMID 12581643 JRNL DOI 10.1016/S0022-2836(02)01382-7 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.2 REMARK 3 NUMBER OF REFLECTIONS : NULL REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.199 REMARK 3 FREE R VALUE : 0.252 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1180 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6614 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 373 REMARK 3 SOLVENT ATOMS : 14 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 44.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.417 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.347 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 17.941 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : 0.009 ; 0.010 REMARK 3 ANGLE DISTANCE (A) : 0.022 ; 0.015 REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : 0.009 ; 0.020 REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : 0.004 ; 0.012 REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : 0.265 ; 0.150 REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : 0.150 ; 0.150 REMARK 3 MULTIPLE TORSION (A) : 0.214 ; 0.150 REMARK 3 H-BOND (X...Y) (A) : 0.136 ; 0.150 REMARK 3 H-BOND (X-H...Y) (A) : 0.160 ; 0.150 REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : 2.500 ; 7.000 REMARK 3 STAGGERED (DEGREES) : 23.200; 15.000 REMARK 3 TRANSVERSE (DEGREES) : 22.800; 20.000 REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.638 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 4.641 ; 5.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 4.306 ; 4.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 6.495 ; 6.000 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1E03 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 09-MAR-00. REMARK 100 THE DEPOSITION ID IS D_1290004667. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX9.6 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.87 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23386 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.2 REMARK 200 DATA REDUNDANCY : 2.500 REMARK 200 R MERGE (I) : 0.12400 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 5.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 1AZX REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.83 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 5MG/ML 1:1 MIX OF INHIBITORY: LATENT REMARK 280 ANTITHROMBIN-III 16% PEG 4000, 63 MM NACACODYLATE PH 7.0, 0.05% REMARK 280 AZIDE, PH 7.00 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 43.53550 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, C, D, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: I, A, B, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 CHAIN I ADOPTS THE INHIBITORY CONFORMATION; REMARK 400 CHAIN L ADOPTS THE LATENT CONFORMATION REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS I 1 REMARK 465 GLY I 2 REMARK 465 SER I 3 REMARK 465 PRO I 4 REMARK 465 VAL I 5 REMARK 465 LYS I 29 REMARK 465 ALA I 30 REMARK 465 THR I 31 REMARK 465 GLU I 32 REMARK 465 ASP I 33 REMARK 465 GLU I 34 REMARK 465 GLY I 35 REMARK 465 SER I 36 REMARK 465 LYS I 432 REMARK 465 HIS L 1 REMARK 465 GLY L 2 REMARK 465 SER L 3 REMARK 465 PRO L 4 REMARK 465 LYS L 28 REMARK 465 LYS L 29 REMARK 465 ALA L 30 REMARK 465 THR L 31 REMARK 465 LYS L 432 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG I 13 CG CD NE CZ NH1 NH2 REMARK 470 MET I 17 CG SD CE REMARK 470 LYS I 28 CG CD CE NZ REMARK 470 GLU I 37 CG CD OE1 OE2 REMARK 470 GLN I 38 CG CD OE1 NE2 REMARK 470 LYS I 39 CG CD CE NZ REMARK 470 LYS I 125 CG CD CE NZ REMARK 470 LYS I 136 CG CD CE NZ REMARK 470 GLN I 181 CG CD OE1 NE2 REMARK 470 LYS I 188 CG CD CE NZ REMARK 470 LYS I 193 CG CD CE NZ REMARK 470 LYS I 287 CG CD CE NZ REMARK 470 ARG I 324 CD NE CZ NH1 NH2 REMARK 470 GLU I 347 CG CD OE1 OE2 REMARK 470 LYS I 350 CG CD CE NZ REMARK 470 ARG I 359 CG CD NE CZ NH1 NH2 REMARK 470 ARG L 24 CG CD NE CZ NH1 NH2 REMARK 470 GLU L 27 CG CD OE1 OE2 REMARK 470 GLU L 32 CG CD OE1 OE2 REMARK 470 GLU L 34 CG CD OE1 OE2 REMARK 470 GLU L 37 CG CD OE1 OE2 REMARK 470 GLN L 38 CG CD OE1 NE2 REMARK 470 LYS L 228 CG CD CE NZ REMARK 470 LYS L 257 CG CD CE NZ REMARK 470 LYS L 290 CG CD CE NZ REMARK 470 LYS L 297 CG CD CE NZ REMARK 470 LYS L 403 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP I 200 CB - CG - OD1 ANGL. DEV. = 5.5 DEGREES REMARK 500 ARG L 47 CD - NE - CZ ANGL. DEV. = 9.9 DEGREES REMARK 500 ARG L 47 NE - CZ - NH1 ANGL. DEV. = 4.3 DEGREES REMARK 500 ASP L 200 CB - CG - OD1 ANGL. DEV. = 5.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET I 20 -73.34 -56.97 REMARK 500 PHE I 77 113.42 176.49 REMARK 500 ASN I 96 -122.41 48.60 REMARK 500 ILE I 111 177.98 -58.86 REMARK 500 ALA I 134 -70.77 -49.38 REMARK 500 LYS I 136 -66.28 -8.29 REMARK 500 SER I 137 -8.04 -141.09 REMARK 500 GLU I 177 -60.43 -101.75 REMARK 500 ASN I 178 38.83 -86.95 REMARK 500 ALA I 179 -84.92 -25.96 REMARK 500 ASN I 208 -155.57 -143.72 REMARK 500 VAL I 263 -159.73 -116.11 REMARK 500 ALA I 264 106.01 -48.68 REMARK 500 GLU I 265 9.85 86.12 REMARK 500 ASP I 277 -6.03 74.86 REMARK 500 LYS I 332 -74.40 -47.80 REMARK 500 VAL I 341 -60.57 -100.69 REMARK 500 ALA I 356 -87.39 -32.10 REMARK 500 ASP I 361 105.00 -48.53 REMARK 500 GLU I 378 0.93 -157.56 REMARK 500 GLU I 381 -6.24 -156.00 REMARK 500 ASN I 398 56.33 -97.64 REMARK 500 PRO I 407 149.90 -36.24 REMARK 500 ASN I 418 23.22 81.87 REMARK 500 ASN I 428 100.84 -169.90 REMARK 500 ASN L 18 119.01 -9.10 REMARK 500 MET L 20 -71.03 -55.04 REMARK 500 PRO L 26 170.15 -55.63 REMARK 500 GLU L 34 94.33 -63.55 REMARK 500 GLN L 38 54.65 73.07 REMARK 500 LYS L 39 131.89 -33.31 REMARK 500 ASN L 96 -133.88 59.13 REMARK 500 SER L 112 153.78 -48.15 REMARK 500 ARG L 132 53.71 -108.95 REMARK 500 LYS L 176 -52.35 -29.90 REMARK 500 ASN L 178 59.18 -108.55 REMARK 500 ASP L 200 43.21 -145.20 REMARK 500 SER L 204 135.55 -37.63 REMARK 500 GLU L 205 -0.54 76.08 REMARK 500 VAL L 212 -63.52 -99.38 REMARK 500 VAL L 263 -160.34 -102.19 REMARK 500 PRO L 288 -65.64 -21.09 REMARK 500 GLU L 298 63.98 -105.98 REMARK 500 MET L 338 1.45 -66.89 REMARK 500 VAL L 341 -66.52 -92.51 REMARK 500 GLU L 357 64.58 -57.65 REMARK 500 ALA L 391 73.21 69.30 REMARK 500 ASN L 398 108.23 -33.39 REMARK 500 ARG L 406 68.38 68.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 ASP L 6 -11.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1ANT RELATED DB: PDB REMARK 900 RELATED ID: 1ATH RELATED DB: PDB REMARK 900 RELATED ID: 2ANT RELATED DB: PDB REMARK 900 RELATED ID: 1BR8 RELATED DB: PDB REMARK 900 RELATED ID: 1DZG RELATED DB: PDB REMARK 900 RELATED ID: 1DZH RELATED DB: PDB REMARK 900 RELATED ID: 1E04 RELATED DB: PDB REMARK 900 RELATED ID: 1E05 RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 ANT3_HUMAN RESIDUE NUMBERING IN SWS IS FROM START REMARK 999 OF ANTITHROMBIN-III LEADER SEQUENCE. REMARK 999 STRUCTURE RESIDUE NUMBERING IS FROM START OF REMARK 999 MATURE ANTITHROMBIN-III REMARK 999 REMARK 999 RESIDUES NOT MODELLED HAD POOR ELECTRON DENSITY DBREF 1E03 L 1 432 UNP P01008 ANT3_HUMAN 33 464 DBREF 1E03 I 1 432 UNP P01008 ANT3_HUMAN 33 464 SEQRES 1 I 432 HIS GLY SER PRO VAL ASP ILE CYS THR ALA LYS PRO ARG SEQRES 2 I 432 ASP ILE PRO MET ASN PRO MET CYS ILE TYR ARG SER PRO SEQRES 3 I 432 GLU LYS LYS ALA THR GLU ASP GLU GLY SER GLU GLN LYS SEQRES 4 I 432 ILE PRO GLU ALA THR ASN ARG ARG VAL TRP GLU LEU SER SEQRES 5 I 432 LYS ALA ASN SER ARG PHE ALA THR THR PHE TYR GLN HIS SEQRES 6 I 432 LEU ALA ASP SER LYS ASN ASP ASN ASP ASN ILE PHE LEU SEQRES 7 I 432 SER PRO LEU SER ILE SER THR ALA PHE ALA MET THR LYS SEQRES 8 I 432 LEU GLY ALA CYS ASN ASP THR LEU GLN GLN LEU MET GLU SEQRES 9 I 432 VAL PHE LYS PHE ASP THR ILE SER GLU LYS THR SER ASP SEQRES 10 I 432 GLN ILE HIS PHE PHE PHE ALA LYS LEU ASN CYS ARG LEU SEQRES 11 I 432 TYR ARG LYS ALA ASN LYS SER SER LYS LEU VAL SER ALA SEQRES 12 I 432 ASN ARG LEU PHE GLY ASP LYS SER LEU THR PHE ASN GLU SEQRES 13 I 432 THR TYR GLN ASP ILE SER GLU LEU VAL TYR GLY ALA LYS SEQRES 14 I 432 LEU GLN PRO LEU ASP PHE LYS GLU ASN ALA GLU GLN SER SEQRES 15 I 432 ARG ALA ALA ILE ASN LYS TRP VAL SER ASN LYS THR GLU SEQRES 16 I 432 GLY ARG ILE THR ASP VAL ILE PRO SER GLU ALA ILE ASN SEQRES 17 I 432 GLU LEU THR VAL LEU VAL LEU VAL ASN THR ILE TYR PHE SEQRES 18 I 432 LYS GLY LEU TRP LYS SER LYS PHE SER PRO GLU ASN THR SEQRES 19 I 432 ARG LYS GLU LEU PHE TYR LYS ALA ASP GLY GLU SER CYS SEQRES 20 I 432 SER ALA SER MET MET TYR GLN GLU GLY LYS PHE ARG TYR SEQRES 21 I 432 ARG ARG VAL ALA GLU GLY THR GLN VAL LEU GLU LEU PRO SEQRES 22 I 432 PHE LYS GLY ASP ASP ILE THR MET VAL LEU ILE LEU PRO SEQRES 23 I 432 LYS PRO GLU LYS SER LEU ALA LYS VAL GLU LYS GLU LEU SEQRES 24 I 432 THR PRO GLU VAL LEU GLN GLU TRP LEU ASP GLU LEU GLU SEQRES 25 I 432 GLU MET MET LEU VAL VAL HIS MET PRO ARG PHE ARG ILE SEQRES 26 I 432 GLU ASP GLY PHE SER LEU LYS GLU GLN LEU GLN ASP MET SEQRES 27 I 432 GLY LEU VAL ASP LEU PHE SER PRO GLU LYS SER LYS LEU SEQRES 28 I 432 PRO GLY ILE VAL ALA GLU GLY ARG ASP ASP LEU TYR VAL SEQRES 29 I 432 SER ASP ALA PHE HIS LYS ALA PHE LEU GLU VAL ASN GLU SEQRES 30 I 432 GLU GLY SER GLU ALA ALA ALA SER THR ALA VAL VAL ILE SEQRES 31 I 432 ALA GLY ARG SER LEU ASN PRO ASN ARG VAL THR PHE LYS SEQRES 32 I 432 ALA ASN ARG PRO PHE LEU VAL PHE ILE ARG GLU VAL PRO SEQRES 33 I 432 LEU ASN THR ILE ILE PHE MET GLY ARG VAL ALA ASN PRO SEQRES 34 I 432 CYS VAL LYS SEQRES 1 L 432 HIS GLY SER PRO VAL ASP ILE CYS THR ALA LYS PRO ARG SEQRES 2 L 432 ASP ILE PRO MET ASN PRO MET CYS ILE TYR ARG SER PRO SEQRES 3 L 432 GLU LYS LYS ALA THR GLU ASP GLU GLY SER GLU GLN LYS SEQRES 4 L 432 ILE PRO GLU ALA THR ASN ARG ARG VAL TRP GLU LEU SER SEQRES 5 L 432 LYS ALA ASN SER ARG PHE ALA THR THR PHE TYR GLN HIS SEQRES 6 L 432 LEU ALA ASP SER LYS ASN ASP ASN ASP ASN ILE PHE LEU SEQRES 7 L 432 SER PRO LEU SER ILE SER THR ALA PHE ALA MET THR LYS SEQRES 8 L 432 LEU GLY ALA CYS ASN ASP THR LEU GLN GLN LEU MET GLU SEQRES 9 L 432 VAL PHE LYS PHE ASP THR ILE SER GLU LYS THR SER ASP SEQRES 10 L 432 GLN ILE HIS PHE PHE PHE ALA LYS LEU ASN CYS ARG LEU SEQRES 11 L 432 TYR ARG LYS ALA ASN LYS SER SER LYS LEU VAL SER ALA SEQRES 12 L 432 ASN ARG LEU PHE GLY ASP LYS SER LEU THR PHE ASN GLU SEQRES 13 L 432 THR TYR GLN ASP ILE SER GLU LEU VAL TYR GLY ALA LYS SEQRES 14 L 432 LEU GLN PRO LEU ASP PHE LYS GLU ASN ALA GLU GLN SER SEQRES 15 L 432 ARG ALA ALA ILE ASN LYS TRP VAL SER ASN LYS THR GLU SEQRES 16 L 432 GLY ARG ILE THR ASP VAL ILE PRO SER GLU ALA ILE ASN SEQRES 17 L 432 GLU LEU THR VAL LEU VAL LEU VAL ASN THR ILE TYR PHE SEQRES 18 L 432 LYS GLY LEU TRP LYS SER LYS PHE SER PRO GLU ASN THR SEQRES 19 L 432 ARG LYS GLU LEU PHE TYR LYS ALA ASP GLY GLU SER CYS SEQRES 20 L 432 SER ALA SER MET MET TYR GLN GLU GLY LYS PHE ARG TYR SEQRES 21 L 432 ARG ARG VAL ALA GLU GLY THR GLN VAL LEU GLU LEU PRO SEQRES 22 L 432 PHE LYS GLY ASP ASP ILE THR MET VAL LEU ILE LEU PRO SEQRES 23 L 432 LYS PRO GLU LYS SER LEU ALA LYS VAL GLU LYS GLU LEU SEQRES 24 L 432 THR PRO GLU VAL LEU GLN GLU TRP LEU ASP GLU LEU GLU SEQRES 25 L 432 GLU MET MET LEU VAL VAL HIS MET PRO ARG PHE ARG ILE SEQRES 26 L 432 GLU ASP GLY PHE SER LEU LYS GLU GLN LEU GLN ASP MET SEQRES 27 L 432 GLY LEU VAL ASP LEU PHE SER PRO GLU LYS SER LYS LEU SEQRES 28 L 432 PRO GLY ILE VAL ALA GLU GLY ARG ASP ASP LEU TYR VAL SEQRES 29 L 432 SER ASP ALA PHE HIS LYS ALA PHE LEU GLU VAL ASN GLU SEQRES 30 L 432 GLU GLY SER GLU ALA ALA ALA SER THR ALA VAL VAL ILE SEQRES 31 L 432 ALA GLY ARG SER LEU ASN PRO ASN ARG VAL THR PHE LYS SEQRES 32 L 432 ALA ASN ARG PRO PHE LEU VAL PHE ILE ARG GLU VAL PRO SEQRES 33 L 432 LEU ASN THR ILE ILE PHE MET GLY ARG VAL ALA ASN PRO SEQRES 34 L 432 CYS VAL LYS MODRES 1E03 ASN I 96 ASN GLYCOSYLATION SITE MODRES 1E03 ASN I 135 ASN GLYCOSYLATION SITE MODRES 1E03 ASN I 155 ASN GLYCOSYLATION SITE MODRES 1E03 ASN L 96 ASN GLYCOSYLATION SITE MODRES 1E03 ASN L 155 ASN GLYCOSYLATION SITE MODRES 1E03 ASN L 192 ASN GLYCOSYLATION SITE HET NAG A 1 14 HET NAG A 2 14 HET NAG B 1 14 HET NAG B 2 14 HET BMA B 3 11 HET NAG C 1 14 HET NAG C 2 14 HET BMA C 3 11 HET NAG D 1 14 HET NAG D 2 14 HET BMA D 3 11 HET Z9L E 1 25 HET Z9K E 2 17 HET GU6 E 3 23 HET GU1 E 4 14 HET Z9H E 5 21 HET Z9L F 1 25 HET Z9K F 2 17 HET GU6 F 3 23 HET GU1 F 4 14 HET Z9H F 5 21 HET NAG I 821 14 HET NAG L 801 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM Z9L METHYL 2,3,6-TRI-O-SULFO-ALPHA-D-GLUCOPYRANOSIDE HETNAM Z9K 3-O-METHYL-2-O-SULFO-ALPHA-L-IDOPYRANURONIC ACID HETNAM GU6 2,3,6-TRI-O-SULFO-ALPHA-D-GLUCOPYRANOSE HETNAM GU1 2,3-DI-O-METHYL-BETA-D-GLUCOPYRANURONIC ACID HETNAM Z9H 3,4-DI-O-METHYL-2,6-DI-O-SULFO-ALPHA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN GU6 2,3,6-TRI-O-SULFONATO-ALPHA-D-GLUCOPYRANOSE; 2,3,6-TRI- HETSYN 2 GU6 O-SULFO-ALPHA-D-GLUCOSE; 2,3,6-TRI-O-SULFO-D-GLUCOSE; HETSYN 3 GU6 2,3,6-TRI-O-SULFO-GLUCOSE HETSYN GU1 2,3-DI-O-METHYL-BETA-D-GLUCURONIC ACID; 2,3-DI-O- HETSYN 2 GU1 METHYL-D-GLUCURONIC ACID; 2,3-DI-O-METHYL-GLUCURONIC HETSYN 3 GU1 ACID FORMUL 3 NAG 10(C8 H15 N O6) FORMUL 4 BMA 3(C6 H12 O6) FORMUL 7 Z9L 2(C7 H14 O15 S3) FORMUL 7 Z9K 2(C7 H12 O10 S) FORMUL 7 GU6 2(C6 H12 O15 S3) FORMUL 7 GU1 2(C8 H14 O7) FORMUL 7 Z9H 2(C8 H16 O12 S2) FORMUL 11 HOH *14(H2 O) HELIX 1 13 ASN I 45 SER I 69 1 25 HELIX 2 14 SER I 79 ALA I 94 1 16 HELIX 3 15 CYS I 95 PHE I 106 1 12 HELIX 4 16 LYS I 107 ILE I 111 5 5 HELIX 5 17 SER I 112 GLN I 118 1 7 HELIX 6 18 GLN I 118 LYS I 136 1 19 HELIX 7 19 ASN I 155 TYR I 166 1 12 HELIX 8 20 ASN I 178 THR I 194 1 17 HELIX 9 21 SER I 230 THR I 234 5 5 HELIX 10 22 ALA I 264 GLY I 266 5 3 HELIX 11 23 SER I 291 LEU I 299 1 9 HELIX 12 24 THR I 300 GLU I 310 1 11 HELIX 13 25 LEU I 331 MET I 338 1 8 HELIX 14 26 VAL I 341 SER I 345 5 5 HELIX 15 1 ASN L 45 SER L 69 1 25 HELIX 16 2 SER L 79 LEU L 92 1 14 HELIX 17 3 CYS L 95 PHE L 106 1 12 HELIX 18 4 SER L 112 ASP L 117 1 6 HELIX 19 5 GLN L 118 ARG L 132 1 15 HELIX 20 6 ASN L 155 VAL L 165 1 11 HELIX 21 7 ASN L 178 THR L 194 1 17 HELIX 22 8 ALA L 264 GLY L 266 5 3 HELIX 23 9 LEU L 292 GLU L 298 1 7 HELIX 24 10 THR L 300 ASP L 309 1 10 HELIX 25 11 LEU L 331 MET L 338 1 8 HELIX 26 12 VAL L 341 SER L 345 5 5 SHEET 1 A 7 ILE L 76 LEU L 78 0 SHEET 2 A 7 THR L 419 VAL L 426 -1 N ARG L 425 O ILE L 76 SHEET 3 A 7 PHE L 408 GLU L 414 -1 N GLU L 414 O THR L 419 SHEET 4 A 7 ILE L 279 LEU L 285 -1 N ILE L 284 O LEU L 409 SHEET 5 A 7 GLN L 268 PRO L 273 -1 N LEU L 272 O MET L 281 SHEET 6 A 7 MET L 251 ARG L 262 -1 N ARG L 261 O VAL L 269 SHEET 7 A 7 GLU L 312 PRO L 321 -1 N MET L 320 O MET L 252 SHEET 1 B 6 LEU L 170 LEU L 173 0 SHEET 2 B 6 LYS L 139 ASP L 149 1 N LEU L 146 O GLN L 171 SHEET 3 B 6 LEU L 213 LEU L 224 -1 N LYS L 222 O LYS L 139 SHEET 4 B 6 GLY L 379 ILE L 390 -1 N ILE L 390 O LEU L 213 SHEET 5 B 6 VAL L 364 VAL L 375 -1 N GLU L 374 O GLU L 381 SHEET 6 B 6 PHE L 323 SER L 330 -1 N PHE L 329 O HIS L 369 SHEET 1 C 2 ARG L 235 TYR L 240 0 SHEET 2 C 2 SER L 246 MET L 251 -1 N MET L 251 O ARG L 235 SHEET 1 D 8 ILE I 76 LEU I 78 0 SHEET 2 D 8 ILE I 420 VAL I 426 -1 N ARG I 425 O ILE I 76 SHEET 3 D 8 PHE I 408 GLU I 414 -1 N ILE I 412 O ILE I 421 SHEET 4 D 8 ILE I 279 LEU I 285 -1 N ILE I 284 O LEU I 409 SHEET 5 D 8 GLN I 268 PRO I 273 -1 N LEU I 272 O MET I 281 SHEET 6 D 8 MET I 251 ARG I 262 -1 N ARG I 261 O VAL I 269 SHEET 7 D 8 GLU I 312 PRO I 321 -1 N MET I 320 O MET I 252 SHEET 8 D 8 VAL I 400 LYS I 403 1 N VAL I 400 O VAL I 317 SHEET 1 E 5 GLN I 171 LEU I 173 0 SHEET 2 E 5 LYS I 139 ASP I 149 1 N GLY I 148 O GLN I 171 SHEET 3 E 5 LEU I 213 LYS I 222 -1 N LYS I 222 O LYS I 139 SHEET 4 E 5 ASP I 366 VAL I 375 1 N ASP I 366 O LEU I 215 SHEET 5 E 5 PHE I 323 SER I 330 -1 N PHE I 329 O HIS I 369 SHEET 1 F 2 ARG I 235 TYR I 240 0 SHEET 2 F 2 SER I 246 MET I 251 -1 N MET I 251 O ARG I 235 SSBOND 1 CYS I 8 CYS I 128 1555 1555 2.01 SSBOND 2 CYS I 21 CYS I 95 1555 1555 2.02 SSBOND 3 CYS I 247 CYS I 430 1555 1555 2.04 SSBOND 4 CYS L 8 CYS L 128 1555 1555 2.02 SSBOND 5 CYS L 21 CYS L 95 1555 1555 2.03 SSBOND 6 CYS L 247 CYS L 430 1555 1555 2.04 LINK ND2 ASN I 96 C1 NAG A 1 1555 1555 1.41 LINK ND2 ASN I 135 C1 NAG I 821 1555 1555 1.38 LINK ND2 ASN I 155 C1 NAG B 1 1555 1555 1.39 LINK ND2 ASN L 96 C1 NAG L 801 1555 1555 1.37 LINK ND2 ASN L 155 C1 NAG C 1 1555 1555 1.39 LINK ND2 ASN L 192 C1 NAG D 1 1555 1555 1.39 LINK O4 NAG A 1 C1 NAG A 2 1555 1555 1.30 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.41 LINK O4 NAG B 2 C1 BMA B 3 1555 1555 1.40 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.40 LINK O4 NAG C 2 C1 BMA C 3 1555 1555 1.41 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.43 LINK O4 NAG D 2 C1 BMA D 3 1555 1555 1.39 LINK O4 Z9L E 1 C1 Z9K E 2 1555 1555 1.42 LINK O4 Z9K E 2 C1 GU6 E 3 1555 1555 1.44 LINK O4 GU6 E 3 C1 GU1 E 4 1555 1555 1.43 LINK O4 GU1 E 4 C1 Z9H E 5 1555 1555 1.43 LINK O4 Z9L F 1 C1 Z9K F 2 1555 1555 1.41 LINK O4 Z9K F 2 C1 GU6 F 3 1555 1555 1.44 LINK O4 GU6 F 3 C1 GU1 F 4 1555 1555 1.42 LINK O4 GU1 F 4 C1 Z9H F 5 1555 1555 1.43 CRYST1 70.511 87.071 97.349 90.00 108.88 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014182 0.000000 0.004850 0.00000 SCALE2 0.000000 0.011485 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010856 0.00000